KAREN DOHERTY-WELLS: Open Payments
NPI 1962494054 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 36 payments from 9 companies in 2025. Trend: 2023 $890 · 2024 $1,297 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $214 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Dexcom, Inc. | 5 | $105 |
| Novo Nordisk Inc | 3 | $52 |
| Amgen Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: BREZTRI, Dexcom G6 Transmitter, VRAYLAR, UBRELVY, QULIPTA, VOQUEZNA, Ozempic, CAPLYTA.
Industry payments across NY — which companies pay providers there.
